Kymera Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
KYMR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
500 North Beacon Street, 4 Th Floor, Watertown, MA

Insiders trading volume in the past year

Kymera Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director $719M +$57.7M +8.72% Jun 30, 2025
Atlas Venture Fund X, L.P. 10%+ Owner $236M Mar 11, 2024
Atlas Venture Associates X, L.P. 10%+ Owner $173M Aug 11, 2021
Nello Mainolfi Chief Executive Officer, Director $40.6M -$4.77M -10.5% Oct 29, 2025
Bruce Booth Director $28.4M Jun 25, 2025
Bvf Partners L P/Il Director, Other* $17.8M +$14M +367% Jun 25, 2025
Bruce N. Jacobs Chief Financial Officer $11.4M -$4.18M -26.9% Sep 17, 2025
Jared Gollob Chief Medical Officer $6.94M -$4.02M -36.7% Oct 15, 2025
Ellen Chiniara Chief Legal Officer $2.48M -$199K -7.42% Mar 3, 2025
Brian Adams Chief Legal Officer $2.32M Sep 3, 2025
Jeremy G. Chadwick Chief Operating Officer $1.95M -$118K -5.7% May 23, 2025
Elaine Caughey Chief Business Officer $570K Mar 1, 2023
Noah Goodman Chief Business Officer $104K Apr 8, 2025
Pamela Esposito Director $0 -$368K -100% Jun 25, 2025
Elena Ridloff Director $0 -$778K -100% Jun 25, 2025
Joanna Horobin Director $0 Jun 7, 2024
Jeffrey W. Albers Director $0 -$607K -100% Oct 13, 2025
Donald William Nicholson Director Jun 15, 2022
Gorjan Hrustanovic Director Jun 25, 2025
Victor Sandor Director Jun 25, 2025
Leigh Morgan Director Jun 18, 2024
Steven Edward Hall Director Jun 16, 2021
John Maraganore Director Jun 25, 2025
Richard Chesworth Chief Scientific Officer Aug 27, 2021

Recent Insider Transactions by Companies or Individuals for Kymera Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.